Proactive - Interviews for investors

Proactive - Interviews for investors

Download on the App Store

Proactive - Interviews for investors episodes

  • Just the Facts: PDI raises A$69M for Bankan Gold Project development
    Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Predictive Discovery Ltd.
    PDI has secured binding commitments from the Lundin Family and Zijin Mining Group for a strategic private placement, raising approximately A$69.2 million at an issue price of A$0.265 per share.
    The Lundin Family will invest A$45.1 million for a 6.5% shareholding, while Zijin Mining Group will contribute A$24.1 million for a 3.5% stake.
    Following the completion of the placement, Predictive Discovery will have a pro-forma cash balance of A$98 million before costs.
    The funds will be directed towards advancing the definitive feasibility study for the Bankan Gold Project in Guinea, supporting environmental and social programs, continuing regional exploration, and initiating early development activities.
    The company has expressed its appreciation for the new strategic shareholders, stating that their investment reflects confidence in the quality of the Bankan Gold Project and PDI’s progress in developing it into a tier-1 gold mine.
    This capital raise will provide PDI with a strong financial foundation to accelerate project development, conduct selected early works, and continue regional exploration programs.
    #PredictiveDiscovery #BankanGoldProject #GoldMining #MiningInvestment #LundinFamily #ZijinMining #GoldExploration #DefinitiveFeasibilityStudy #GuineaMining #ResourceDevelopment #GoldProduction #FeasibilityStudy #MiningFinance #ExplorationFunding #GoldProject #MiningNews #MiningSector #ResourceExploration #MineralDevelopment #MiningIndustry
    2 min
  • Just the Facts: NGX boosts graphite yields with new processing technology
    Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from NGX Limited.
    NGX has successfully produced additional spherical graphite (SG) from previously rejected fines material, converting low-value waste into high-value precursor anode material.
    This advancement, achieved in collaboration with international technology partners, has the potential to improve production yields beyond industry standards and enhance project economics.
    The development is part of NGX’s anode material program, focused on pre-qualifying anode material from natural flake graphite at the Malingunde Graphite Project in Malawi.
    By repurposing fines typically discarded during the spheronisation process, the company aims to increase sustainability and production efficiency.
    Initial test results confirm that the SG produced meets industry benchmarks, with a D50 of 16.7 microns, a tap density of 0.985, and a BET-specific surface area of 7.3 m²/g, achieving a 43% yield.
    Further optimisation is underway to refine the material to a finer D50 of 10.7 microns, which is in high demand for fast-charging lithium-ion battery applications. Processing of fines has already improved overall yields by 24%.
    The first batch of finer-sized SG samples has been sent for purification testing, with results expected later this quarter. NGX continues to refine its process to maximise yields and improve product performance.
    #NGX #Graphite #BatteryMaterials #SphericalGraphite #LithiumIonBatteries #AnodeMaterials #EnergyStorage #BatteryTech #Sustainability #GraphiteMining #ElectricVehicles #CriticalMinerals #ResourceEfficiency #TechInnovation #MiningNews #GreenEnergy #GraphiteMarket #BatteryInnovation #CleanEnergy #MaterialScience
    3 min
  • Just the Facts: Orthocell seeks Canadian approval for Remplir™
    Proactive’s Tylah Tully breaks down ‘Just the Facts’ of the latest news from Orthocell Ltd.
    Orthocell has applied for regulatory approval from Health Canada to sell its nerve repair product, Remplir™, in the Canadian market, which is valued at approximately US$75 million.
    The company expects regulatory clearance in the second half of 2025.
    Remplir™ is a collagen wrap used in nerve repair surgeries and is already approved for use in Australia, New Zealand and Singapore, where it has experienced strong sales growth.
    Orthocell is actively expanding into new markets, with regulatory submissions planned for Thailand in the March quarter of 2025, the UK and EU in the September quarter and Brazil in the December quarter.
    In addition to these markets, Orthocell anticipates receiving US FDA 510(k) clearance for Remplir™ by late March or early April 2025, which would enable its entry into the US nerve repair market, valued at US$1.6 billion.
    Orthocell has approximately AU$33 million in cash reserves to support its expansion efforts. The company aims for a 20% market share within a combined global market estimated at US$3.2 billion.
    To facilitate its US market entry, Orthocell has appointed US-based executives and is developing key opinion leader engagements, distributor partnerships, and medical education initiatives.
    #Orthocell #Remplir #MedicalDevices #NerveRepair #HealthCanada #FDAApproval #SurgicalInnovation #RegenerativeMedicine #Healthcare #MedicalTechnology #MarketExpansion #GlobalHealth #Orthopaedics #PlasticSurgery #HealthcareInnovation #ASX #InvestorNews #Biotech #MedTech #Surgery
    2 min
  • Onco-Innovations Advances Next-Gen Cancer Therapy With PNKP Inhibitor & AI Partnership
    Onco-Innovations CEO Thomas O’Shaughnessy joined Steve Darling from Proactive to discuss the company’s cutting-edge approach to cancer treatment in response to the projected 47-48% rise in global cancer cases by 2040. The company is pioneering next-generation therapies based on precision medicine and nanotechnology, with an initial focus on solid tumors, particularly colorectal cancer.
    O’Shaughnessy highlighted that Onco-Innovations’ patented drug formulation and nanoparticle technology are designed to enhance chemotherapy and radiation by making cancer cells more susceptible to treatment. Central to its innovation is a licensed PNKP inhibitor, a new class of drug that blocks cancer cells from repairing DNA damage, making existing therapies more effective. Additionally, the company is leveraging nanoparticle delivery systems to improve drug targeting and efficiency.
    Further strengthening its position in precision oncology, Onco-Innovations recently signed a Letter of Intent (LOI) with Inka Health AI, a company specializing in AI-driven oncology diagnostics. This partnership aims to enhance personalized cancer treatment strategies by integrating patient-specific data into therapy development.
    O’Shaughnessy expressed excitement about Onco-Innovations’ growth following its IPO, emphasizing the company’s commitment to transforming cancer care through cutting-edge research and strategic collaborations.
    #proactiveinvestors #once-innovationslimited #cse #onco #CancerTreatment #PrecisionMedicine #Biotech #Oncology #CancerResearch #Pharma #Healthcare #MedicalBreakthrough #AIinMedicine
    9 min
  • New Era Helium and Sharon AI Finalize JV to Develop 250MW Net-Zero Data Center in Texas
    New Era Helium CEO Will Gray joined Steve Darling from Proactive to announce the finalization of a 50/50 joint venture with Sharon AI, a high-performance computing company specializing in AI, Cloud GPU Compute Infrastructure, and Cloud Storage. The partnership has formed Texas Critical Data Centers, which will develop a 250MW net-zero energy data center in the Permian Basin.
    New Era Helium is currently negotiating a long-term offtake gas supply agreement with Texas Critical Data Centers, expected to be finalized within 30 days. The agreement will secure a fixed natural gas price for five years, with options to extend up to 20 years.
    Texas Critical Data Centers has identified multiple potential sites in the Permian Basin with access to New Era Helium’s natural gas supply via existing transmission lines. The final site selection is expected to be announced in Q1 2025.
    Key next steps include securing site entitlements, selecting power generation and CO₂ capture technology, and advancing discussions with potential offtake partners, including hyperscalers and large energy users.
    Looking ahead to 2025, Gray emphasized the company’s commitment to commencing helium sales from the Pegasus Slope field and progressing its 250-megawatt net-zero power project.
    #proactiveinvestors #neweraheliuminc #nasdaq #nehc #oil #gas #perimianbasin #HeliumMarket #NaturalGas #AIDataCenters #NetZero #NasdaqListing #EnergyTransition #Semiconductors #ProactiveInvestors
    7 min
  • First Phosphate CEO shares thoughts on U.S. Tariffs: Impact on Canada’s critical minerals
    First Phosphate CEO John Passalacqua joined Steve Darling from Proactive to discuss the company’s strategic position in the critical minerals sector amid recent U.S. tariff discussions. Speaking from the Canadian Consulate in New York during a critical minerals conference, Passalacqua emphasized Canada’s unique advantage in mining high-quality phosphate, an essential component for lithium-ion batteries.
    Passalacqua explained that First Phosphate’s operations in Quebec provide a non-relocatable critical resource. He noted that secondary processing—such as phosphoric acid production—must remain close to the source to maintain operational efficiency. He suggested that potential U.S. tariffs could further stimulate investment into Canada’s mining sector, accelerating major projects and infrastructure development.
    Addressing regulatory challenges, Passalacqua pointed out that economic pressures might compel the Canadian government to fast-track approvals and reduce red tape, benefiting large-scale mining projects like First Phosphate’s. He also highlighted the importance of domestic investment from pension funds and financial institutions, which could strengthen Canada’s leadership in the critical minerals market.
    “Canada has to start investing in its own projects,” Passalacqua stated, emphasizing that mining and infrastructure initiatives are vital for the country’s economic stability. He concluded by underscoring Canada’s essential role in the global supply chain for critical battery materials.
    #proactiveinvestors #firstphosphatecorp #cse #phos #otcqb #frspf #phosphate #CriticalMinerals #MiningCanada #USATariffs #LithiumBatteries #PhosphateMining #CanadaEconomy #Infrastructure #MiningInvestment #QuebecResources
    7 min
  • Hivello launches public token sale for HVLO, pioneering DePIN mining for passive income
    Blockmate Ventures CEO Justin Rosenberg joined Steve Darling from Proactive to announce that its subsidiary, Hivello Holdings Ltd has commenced a public token sale event for its native token.
    The Hivello platform offers its users a passive income stream in exchange for their unutilized computing power to third party networks.
    Blockmate will not be directly issuing any tokens or receive any proceeds from the public token sale.
    The token will be issued by the Swiss-based HVLO Association, under licence from Hivello Holdings Ltd.
    Rosenberg told Proactive the $HVLO token sale is structured as a fair launch, ensuring that every participant receives the same terms. This approach underscores Hivello's commitment to decentralization and fairness in the rapidly evolving Web3 landscape.
    Hivello's unique approach to DePIN mining allows users to earn rewards by connecting unused computer resources to decentralized networks. The platform's aspirational goal to integrate with every reputable DePIN positions it as a future leader in the DePIN ecosystem.
    #Hivello #DePIN #Blockchain #Crypto #PassiveIncome #Web3 #Bitcoin #ZuluPartnership #TechInnovation #ProactiveInvestors #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews #BlockchainInvestment #Crypto2025 #TonyGuoga #PassiveIncome #CryptoGrowth #Hivello #DigitalInfrastructure #BlockchainTechnology#TokenSale #HVLO #Blockchain #PassiveIncome #DPIN #DeFi #CryptoNews
    4 min
  • Condor Resources uncovers new Copper-Molybdenum potential at Rio Bravo project in Peru
    Condor Resources CEO Chris Buncic joined Steve Darling from Proactive to announce the company’s evaluation of historical technical data from its Rio Bravo project in Peru, previously owned by a major international mining company. The data includes 11 drill holes from 2012, totaling 5,729 meters, along with drill logs, assay results, core photographs, and extensive technical studies such as soil geochemistry, ground geophysics, magnetometry, radiometry, and induced polarization, covering 20 km² of detailed geological mapping.
    Buncic revealed that the combined analysis of this historical data and Condor’s surface exploration indicates the potential for a significant new deposit with high-grade copper and molybdenum. These minerals are predominantly found in primary sulfides, starting from surface and extending below an observed leached cap. Historical drilling targeted the contact zone between geological assemblages, but the porphyry-type mineralizing system remains open in all directions, suggesting further potential.
    Importantly, the main Cu-Mo core target in the NW sector remains largely untested, as prior drilling focused on peripheral zones. Based on a comprehensive data review, Condor’s exploration team believes that drilling the untouched core of the intrusive porphyry system could uncover substantial resources, positioning Rio Bravo as a key asset in the company’s portfolio.
    #proactiveinvestors #condorresourcesinc #tsxv #cn #MiningUpdate #PucamayoProject #MiningNews #Copper #Molybdenum #RioBravo #PeruMining #MiningInvestment #DrillingResults #NaturalResources #InvestorUpdates
    4 min
  • Ocean Power Technologies secures 2-million-dollar order for next-gen PowerBuoys in Latin America
    Ocean Power Technologies CEO Philipp Stratmann joined Steve Darling from Proactive to announce the company’s latest partnership, which includes $2 million in initial purchase orders for its Next Generation PowerBuoys in Latin America. These cutting-edge systems leverage wave, solar, and wind power to provide sustainable and long-duration offshore energy solutions.
    The Next Generation PowerBuoy is designed for deployment in coastal and deep-ocean waters, supporting payloads both above and below the surface. Equipped with advanced communication capabilities, the system enhances marine intelligence and remote monitoring. This major order reflects the increasing demand for OPT’s innovative solutions and strengthens its position as a leader in marine robotics and intelligence technology.
    Stratmann highlighted that this deal builds on the company’s growing WAM-V (Wave Adaptive Modular Vessel) solutions in the region. The addition of permanent monitoring and marine intelligence capabilities will complement existing roaming solutions, further enhancing maritime operations. OPT remains committed to delivering transformative technology that redefines the future of ocean-based intelligence and sustainability.
    #proactiveinvestors #oceanpowertechnologiesinc #nyseamerican #optt #PhillipStratmann, #USGovernmentContract, #OffshoreAutonomy, #MaritimeSecurity, #CommercialPlatforms, #GrowthStrategy, #BuoyBusiness, #VehicleBusiness, #InternationalExpansion, #ReadyToDeploy
    5 min
  • Imugene’s $20 million boost and cancer trial updates
    Imugene Ltd chief operating officer Brad Glover and managing director and CEO Leslie Chong talked with Proactive’s Tylah Tully about the company’s latest Appendix 4C quarterly report, which provided several key updates for shareholders and investors.
    The pair also discussed the recent $20 million received from CVI Investments, ongoing clinical trials and financial outlook for 2025.
    Chong provided updates on Imugene’s metastatic advanced solid tumour study (MARS), highlighting that a cholangiocarcinoma patient has been in full remission for over two years.
    She also shared news on the company securing a patent for its CF33 oncolytic virus technology, which extends until 2040.
    Glover discussed progress in Imugene’s oncolytic virus program, stating that the company has initiated a combination trial with a CD19-targeting bispecific antibody.
    He also detailed the expansion of the Azer-cel trial, noting that the first Australian site has opened, and initial results from US sites have been promising.
    Financially, Chong reported that Imugene has approximately $65.4 million in cash, ensuring funding through 2025.
    Looking ahead, Glover emphasised the company’s focus on clinical execution and data generation in 2025.
    #Imugene #CancerResearch #Biotech #ClinicalTrials #OncolyticVirus #Immunotherapy #StockMarket #ASX #MedicalInnovation
    8 min

About Proactive - Interviews for investors

From the publisher's feed

Welcome to the Proactive podcast channel – the destination for breaking news on growth companies and up to the minute market coverage.

More shows like Proactive - Interviews for investors

Autoline Daily by Autoline

Autoline Daily

80 Listeners

ev.news by Martyn Lee

ev.news

468 Listeners